No Data
Shenzhen Weiguang Biological Products Co., Ltd.'s (SZSE:002880) Shares Lagging The Market But So Is The Business
Shen zhen weiguang biological products (002880.SZ): Director and Chief Financial Officer Yue Zhangbiao has resigned.
Shen Zhen Weiguang Biological Products (002880.SZ) announced on November 29 that the board of directors of the company recently received the resignation report submitted by Mr. Yue Zhangbiao, the director and chief financial officer of the company. Due to personal reasons, Mr. Yue Zhangbiao resigned from the positions of director and chief financial officer of the company, and will no longer hold any position in the company after resignation.
Weiguang Biotech: Report for the third quarter of 2024
shen zhen weiguang biological products (002880.SZ) released its performance for the first three quarters, with a net income of 0.183 billion yuan, a year-on-year increase of 20.80%.
shen zhen weiguang biological products (002880.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue...
Shen Zhen Weiguang Biological Products (002880.SZ): net income of 0.183 billion yuan in the first three quarters, a year-on-year increase of 20.80%.
Shen Zhen Weiguang Biological Products (002880.SZ) announced its third quarter report for 2024 on October 25th. The company achieved revenue of 0.854 billion yuan in the first three quarters, a year-on-year increase of 16.14%; net income attributable to shareholders of the listed company was 0.183 billion yuan, a year-on-year increase of 20.80%; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 0.178 billion yuan, a year-on-year increase of 20.48%; basic earnings per share was 0.8056 yuan.
Is Shenzhen Weiguang Biological Products (SZSE:002880) Using Too Much Debt?
Some Shareholders Feeling Restless Over Shenzhen Weiguang Biological Products Co., Ltd.'s (SZSE:002880) P/E Ratio
